Loading clinical trials...
Loading clinical trials...
The present phase III study aims to evaluate the safety and immunogenicity of MF59-adjuvanted subunit seasonal influenza vaccine and to evaluate the consistency in the manufacturing process of three c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Vaccines
NCT01386424 · Zika, Influenza
NCT07169318 · Influenza
NCT05648448 · Influenza, Influenza, Human
NCT07291635 · Influenza
NCT06599658 · COVID 19, Influenza, and more
301, Tatum Highlands Medical Associates PLLC, 26224 N Tatum Blvd 15A
Phoenix, Arizona
318 Avail Clinical Research, 860 Peachwood Drive
DeLand, Florida
306 Westside Center for Clinical Research, 810 Lane Avenue South
Jacksonville, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions